Universitätsklinikum Leipzig

A key role of polyamine metabolism in adipose tissue homeostasis that regulates obesity (2025) Mund C, Sinha A, Aderhold A, Mateska I, Hagag E, Traikov S, Gercken B, et al. Journal article Outcome of systemic therapy in patients with advanced rare skin cancers: A retrospective multicenter DeCOG study of 209 patients (2025) Ugurel S, Abu Rached N, Gambichler T, Mengoni M, Tüting T, Hassel JC, Reschke R, et al. Journal article Novel aryl hydrocarbon receptor agonists as potential anti-inflammatory therapeutics: Identification and validation through drug repurposing (2025) Haupt J, Keminer O, Neser C, Windshügel B, Wiltzsch V, Schmidt JR, Pliushcheuskaya P, et al. Journal article Intravenous thrombolysis before percutaneous coronary intervention in patients with non-ST-elevation acute coronary syndrome and acute ischaemic stroke: a subanalysis of the PRAISE study (2025) Sedghi A, Von Rennenberg R, Petzold G, Nickenig G, Kallmünzer B, Achenbach S, Huber R, et al. Journal article Sex-specific survival in advanced metastatic melanoma – a DeCOG study on 2032 patients of the multicenter prospective skin cancer registry ADOREG (2025) Leven AS, Peters T, Rajcsanyi LS, Weichenthal M, Mohr P, Meier F, von Wasielewski I, et al. Journal article The influence of antibiotic and mechanical bowel preparation on the microbiome in colorectal cancer surgery: A pilot study (2025) Lange UG, Lehr K, Thieme R, Hoffmeister A, Feisthammel J, Gockel I, Link A, Jansen-Winkeln B Journal article First-in-Human Study of MDG1011, a TCR-T Therapy Directed Against HLA-A*02:01-Restricted PRAME Antigen for High-Risk Myeloid and Lymphoid Neoplasms (2025) Thomas S, Wermke M, Vučinić V, Wagner-Drouet E, Mackensen A, Zeiser R, Bug G, et al. Journal article Outcomes of bispecific antibody therapy after CAR T-cell failure in relapsed/refractory large B-cell lymphoma (2025) Shumilov E, Scholz JK, Seib M, Mazzeo P, Wurm-Kuczera R, Vucinic V, Holtick U, et al. Journal article Molecular pathology and antibody–drug conjugates: Light at the end of the tunnel for recurrent ovarian cancer Molekularpathologie und Antikörper-Wirkstoff-Konjugate: Licht am Ende des Tunnels beim rezidivierten Ovarialkarzinom (2025) Lüftner D, Erber R, Ataseven B, Lordick F Journal article Real-world experience with first- versus second-line cemiplimab for advanced basal cell carcinoma. (2025) DeTemple VK, Kaatz M, Stockfleth E, Scheel C, Angela Y, Gutzmer R, Leiter U, et al. Journal article